CP
RDY icon

Canopy Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Canopy Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Sell
16,756
-2,740
-14% -$37K 0.07% 208
2026
Q1 		$270K Sell
19,496
-178
-0.9% -$2.48K 0.09% 178
2025
Q4 		$276K Sell
19,674
-1,165
-6% -$16.3K 0.09% 176
2025
Q3 		$291K Buy
20,839
+395
+2% +$5.68K 0.1% 163
2025
Q2 		$307K Buy
20,444
+3,893
+24% +$55.6K 0.11% 151
2025
Q1 		$218K Sell
16,551
-2,750
-14% -$37.9K 0.09% 184
2024
Q4 		$305K Buy
19,301
+376
+2% +$5.65K 0.12% 141
2024
Q3 		$301K Buy
18,925
+575
+3% +$9.25K 0.13% 138
2024
Q2 		$280K Buy
18,350
+1,765
+11% +$25.3K 0.13% 138
2024
Q1 		$243K Buy
+16,585
New +$242K 0.12% 151

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Canopy Partners's RDY Position: Q2 2026 in Review

Canopy Partners reduced its Dr. Reddy's Laboratories (RDY) stake by 14% in Q2 2026, selling an estimated $37K and leaving 16,756 shares worth $243K. The position accounts for 0.07% of the portfolio, ranked #208.

Canopy Partners first reported a position in RDY in Q1 2024 and has held it in 10 quarters since. The position peaked at $307K in Q2 2025. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Canopy Partners held 16,756 shares of Dr. Reddy's Laboratories worth $243K as of Q2 2026.
  • Canopy Partners sold 2,740 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $37K.
  • Dr. Reddy's Laboratories made up 0.07% of Canopy Partners's portfolio in Q2 2026, its #208 holding.
  • Canopy Partners first reported a position in Dr. Reddy's Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Canopy Partners's Dr. Reddy's Laboratories position peaked at $307K in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.